{"id":"629b5cefc7d0","type":"article","url":"https://hartvaat.nl/2025/12/18/2025-acc-aha-richtlijn-voor-behandeling-van-volwassenen-met-aangeboren-hartafwij/","title":"2025 ACC/AHA-richtlijn voor behandeling van volwassenen met aangeboren hartafwijkingen","title_en":"2025 ACC/AHA/HRS/ISACHD/SCAI Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines","category":"algemeen","category_label":"Algemeen","professions":["cardioloog"],"tags":[],"journal":"Circulation","doi":"https://www.ahajournals.org/doi/abs/10.1161/CIR.0000000000001402","source_url":"https://doi.org/https://www.ahajournals.org/doi/abs/10.1161/CIR.0000000000001402","authors":["Michelle Gurvitz"],"significance":9,"published":"2025-12-18","source_date":"2025-12-18","image":"","kennis":[],"congress":"","summary_en":"The 2025 ACC/AHA/HRS/ISACHD/SCAI guideline for adults with congenital heart disease (Circulation edition) provides comprehensive, updated recommendations covering surgical indications, electrophysiology management, pregnancy counseling, and lifelong follow-up for this growing patient population.","created":"2026-07-03T10:25:40Z","updated":"2026-07-03T13:25:03Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"Deze richtlijn van het ACC/AHA/HRS/ISACHD/SCAI biedt aanbevelingen voor evaluatie en behandeling van volwassenen met aangeboren hartafwijkingen, met als doel de levenslange cardiovasculaire zorg te optimaliseren.","abstract_original":"Circulation, Volume 153, Issue 8, Page e115-e251, February 24, 2026. AIMThe “2025 ACC/AHA/HRS/ISACHD/SCAI Guideline for the Management of Adults With Congenital Heart Disease” provides recommendations to guide clinicians on the evaluation and treatment of adult patients with congenital heart disease. It incorporates new evidence to replace the “2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease.”METHODSA comprehensive literature search was conducted with a focus on literature published from 2017 to 2024; in some instances, older literature was also collected and reviewed. Clinical studies, systematic reviews and meta-analyses, and other evidence conducted on human participants and published in English were identified from MEDLINE (via PubMed), EMBASE, the Cochrane Library, Agency for Healthcare Research and Quality, and CINAHL for selected searches.STRUCTURERecommendations from the “2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart"}